Seneca Growth Capital VCT (HYG) Share Price, News & Analysis

Company Overview

Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.

Key Stats

• Today's Range: 4.50 to 8
• 50-Day Range: 4.50 to 13
• 52-Week Range: 4.50 to 13.50
• Volume: 3,413 shs
• Average Volume: 10,204 shs
• Market Capitalization: £365.40 thousand
• P/E Ratio: N/A
• Dividend Yield: 88.89%
• Price Target: N/A
• Consensus Rating: N/A

HYG Stock Analysis - Frequently Asked Questions

How have HYG shares performed this year?

Seneca Growth Capital VCT's stock was trading at GBX 11.50 at the start of the year. Since then, HYG stock has decreased by 60.9% and is now trading at GBX 4.50.
View the best growth stocks for 2025 here.

How were Seneca Growth Capital VCT's earnings last quarter?

Seneca Growth Capital VCT (LON:HYG) released its quarterly earnings data on Wednesday, April, 23rd. The company reported ($0.20) EPS for the quarter.

How do I buy shares of Seneca Growth Capital VCT?

Shares of HYG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Seneca Growth Capital VCT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Seneca Growth Capital VCT investors own include SCYNEXIS (SCYX), HSBC FTSE 100 UCITS ETF (HUKX), GSK (GSK), Frontera Resources (FRR), Cardiff Oncology (CRDF) and Bloom Energy (BE).

Company Calendar

• Last Earnings: 4/23/2025
• Today: 6/15/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:HYG
• CIK: N/A
• Web: www.hygeavct.com
• Phone: +44-1280-703482
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.17)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£2.67 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -15.25%
• Return on Assets: -9.31%

Debt

• Debt-to-Equity Ratio: -69.45
• Current Ratio: 28.38
• Quick Ratio: 51.51

Sales & Book Value

• Annual Sales: -£2.40 million
• Price / Sales: -0.15
• Cash Flow: GBX 4.67 per share
• Price / Cash Flow: 0.96
• Book Value: GBX 56 per share
• Price / Book: 0.08

Miscellaneous

• Outstanding Shares: 8,120,000
• Free Float: N/A
• Market Cap: £365.40 thousand
• Optionable: Not Optionable
• Beta: 0.39